Advertisements


Provention CEO says creating new pharmaceutical category for autoimmunity

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Oscars to Add ‘Popular Film’ Category, Creating Questions

By adding a new category, the Academy Awards risk signaling that blockbuster films are not worthy of consideration for the best overall picture honor......»»

Category: mediaSource: nytAug 8th, 2018

Takeda shareholders approve Shire acquisition: spokesman

Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire , a Takeda spokesman said, creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt......»»

Category: topSource: reutersDec 4th, 2018

Takeda shareholders give nod for $59 billion Shire acquisition

Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire , creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt......»»

Category: topSource: reutersDec 4th, 2018

Takeda investors back $59 billion Shire deal, but wary of debt load

Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire , creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt......»»

Category: topSource: reutersDec 5th, 2018

$59bln: What it costs to become a drugs player

Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire, creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt. Julian Satterthwaite reports......»»

Category: videoSource: reutersDec 5th, 2018

Takeda clears key hurdle as investors back $59 billion Shire deal

Takeda Pharmaceutical has won shareholder approval for its $59 billion takeover of London-listed Shire , creating a global powerhouse that has a stronger drugs pipeline but is also saddled with massive debt......»»

Category: topSource: reutersDec 5th, 2018

San Francisco sues McKesson and others for fueling opioid crisis

San Francisco City Attorney Dennis Herrera filed a lawsuit Tuesday in federal court suing McKesson and other pharmaceutical companies for their alleged role in creating the nation's current opioid crisis. The suit broadly alleges that the defendant.....»»

Category: topSource: bizjournalsDec 19th, 2018

Bristol-Myers bulks up with $74 billion deal to buy Celgene

Bristol-Myers Squibb Co said on Thursday it would buy Celgene Corp for about $74 billion, creating one of the biggest pharmaceutical companies and combining two significant cancer drug businesses......»»

Category: topSource: reutersJan 3rd, 2019

Takeda closes $62B purchase of Shire, creating largest Mass. biotech employer

Takeda Pharmaceutical Co. Ltd. and Shire plc finalized their record-setting tie-up Monday, creating what will likely be Massachusetts' largest life science employer and one of the world's largest drug companies. The Japanese drugmaker announced la.....»»

Category: topSource: bizjournalsJan 7th, 2019

Court ruling annuls PPA, creating potential setback for bioenergy plant

On June 10 the state Supreme Court annulled the original amended power purchase agreement between Hawaii Electric Light and Hu Honua Bioenergy, creating another potential setback for the energy plant. According to court documents, the state's Publi.....»»

Category: topSource: bizjournals5 hr. 35 min. ago

How to Write Copy That Sells High-End Homes

Summarizing the best features of a property with real estate descriptions is just as important as great photography. Writing in a friendly yet professional tone is a challenge in itself, let alone creating a hooky introduction that leaves the reader wanti.....»»

Category: realestateSource: rismedia10 hr. 19 min. ago

YouTube has a kids problem and it's not going away

The Google owned network has come under fire for showing videos to children that aren't appropriate. Children's programming is the No. 1 category on You.....»»

Category: topSource: usatoday10 hr. 34 min. ago

Russian Parliament OKs Cannabis, Psychotropic Cultivation For Pharmaceutical Reasons

Russian parliament has passed a law that would allow the cultivation of psychoactive plants, including cannabis and opium poppies, for pharmaceutical purposes. The move aims to cover the country's needs for painkillers amid sanctions. read more.....»»

Category: blogSource: benzinga10 hr. 49 min. ago

Commit To Buy La Jolla Pharmaceutical Co. At $7, Earn 36.8% Annualized Using Options

Stock Options Channel.....»»

Category: topSource: redinews12 hr. 49 min. ago

Takeda Pharmaceutical management to meet with UBS

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall19 hr. 19 min. ago

CURE Pharmaceutical, Canopy Growth partner to develop CBD oral thin films

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall19 hr. 19 min. ago

Biohaven Pharmaceutical 6.98M share Secondary priced at $43.00

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall19 hr. 19 min. ago

Canopy Growth, CURE Pharmaceutical To Work Together On CBD Oral Thin Films

Drug delivery and development company CURE Pharmaceutical Holding Corp (OTC: CURR) has entered into a partnership with Canadian cannabis giant Canopy Growth Corp (NYSE: CGC) to develop a CBD product together. read more.....»»

Category: blogSource: benzinga19 hr. 19 min. ago

Provention Bio May Offer New Hope For People With Type 1 Diabetes With Latest Clinical Data

Provention Bio May Offer New Hope For People With Type 1 Diabetes With Latest Clinical Data.....»»

Category: topSource: seekingalphaJun 19th, 2019

Three questions with Steve Novak of Hawaii Society of Business Professionals

During his one-year term as president of the Hawaii Society of Business Professionals, Steve Novak says he wants to focus on two things: creating resources and educating business owners. Novak, who has been in the consulting industry for more than .....»»

Category: topSource: bizjournalsJun 18th, 2019